Market3,4-Dihydroxyphenylacetaldehyde
Company Profile

3,4-Dihydroxyphenylacetaldehyde

3,4-Dihydroxyphenylacetaldehyde (DOPAL), also known as dopamine aldehyde, is a metabolite of the monoamine neurotransmitter dopamine formed by monoamine oxidase (MAO).

Dopaminergic neurotoxicity
DOPAL is known to be a dopaminergic neurotoxin. It is much more potent in this regard than dopamine itself and other metabolites of dopamine. DOPAL is detoxified mainly by aldehyde dehydrogenase (ALDH). Aldehyde dehydrogenase inhibitors (ALDH inhibitors), which prevent the catabolism of DOPAL and thereby increase DOPAL levels, can produce dopaminergic neurotoxicity or augment dopaminergic neurodegeneration. Examples of ALDH inhibitors include disulfiram and other known dopaminergic neurotoxins including benomyl, daidzin, dieldrin, methylmercury, rotenone, and ziram. DOPAL itself is also known to inhibit ALDH at high concentrations (>5μM). ==See also==
tickerdossier.comtickerdossier.substack.com